Selected research
Industry Growth & Trends
Global SPECT Radiopharmaceuticals Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global SPECT Radiopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the SPECT Radiopharmaceuticals market include Siemens Healthineers, NorthStar Medical Radioisotopes, Molecular Imaging, Inc., Lantheus Medical Imaging, IBA Molecular Imaging, GE Healthcare, Eczacibasi-Monrol, Curium Pharma and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global SPECT Radiopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The SPECT Radiopharmaceuticals market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SPECT Radiopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SPECT Radiopharmaceuticals.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global SPECT Radiopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
SPECT Radiopharmaceuticals Market by Company
Siemens Healthineers
NorthStar Medical Radioisotopes
Molecular Imaging, Inc.
Lantheus Medical Imaging
IBA Molecular Imaging
GE Healthcare
Eczacibasi-Monrol
Curium Pharma
Cardinal Health
Bracco Imaging
Bayer (Radiology Division)
Advanced Accelerator Applications
SPECT Radiopharmaceuticals Segment by Type
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Gallium-67 (Ga-67)
Iodine-123 (I-123) Based Agents
Technetium-99m (Tc-99m) Based Agents
SPECT Radiopharmaceuticals Segment by Application
Cardiac Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Cancer Imaging
SPECT Radiopharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of SPECT Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of SPECT Radiopharmaceuticals companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Indium-111 (In-111) Based Agents
- Thallium-201 (Tl-201)
- Gallium-67 (Ga-67)
- Iodine-123 (I-123) Based Agents
- Technetium-99m (Tc-99m) Based Agents
Applications
- Cardiac Imaging
- Brain Imaging
- Thyroid Imaging
- Infection and Inflammation Imaging
- Cancer Imaging
Companies covered
- Siemens Healthineers
- NorthStar Medical Radioisotopes
- Molecular Imaging, Inc.
- Lantheus Medical Imaging
- IBA Molecular Imaging
- GE Healthcare
- Eczacibasi-Monrol
- Curium Pharma
- Cardinal Health
- Bracco Imaging
- Bayer (Radiology Division)
- Advanced Accelerator Applications
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global SPECT Radiopharmaceuticals Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global SPECT Radiopharmaceuticals Market Size by Region (2021-2032)
- 1.4.1 Global SPECT Radiopharmaceuticals Market Size by Region (2021-2026)
- 1.4.2 Global SPECT Radiopharmaceuticals Market Size by Region (2027-2032)
- 1.5 Key Regions SPECT Radiopharmaceuticals Market Size (2021-2032)
- 1.5.1 North America SPECT Radiopharmaceuticals Market Size Growth Rate (2021-2032)
- 1.5.2 Europe SPECT Radiopharmaceuticals Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size Growth Rate (2021-2032)
- 1.5.4 South America SPECT Radiopharmaceuticals Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa SPECT Radiopharmaceuticals Market Size Growth Rate (2021-2032)
2 SPECT Radiopharmaceuticals Market by Type
- 2.1 Type Introduction
- 2.1.1 Indium-111 (In-111) Based Agents
- 2.1.2 Thallium-201 (Tl-201)
- 2.1.3 Gallium-67 (Ga-67)
- 2.1.4 Iodine-123 (I-123) Based Agents
- 2.1.5 Technetium-99m (Tc-99m) Based Agents
- 2.2 Global SPECT Radiopharmaceuticals Market Size by Type
- 2.2.1 Global SPECT Radiopharmaceuticals Market Size Overview by Type (2021-2032)
- 2.2.2 Global SPECT Radiopharmaceuticals Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global SPECT Radiopharmaceuticals Market Size Forecasted by Type (2027-2032)
- 2.3 Global SPECT Radiopharmaceuticals Market Size by Regions
- 2.3.1 North America SPECT Radiopharmaceuticals Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe SPECT Radiopharmaceuticals Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America SPECT Radiopharmaceuticals Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa SPECT Radiopharmaceuticals Market Size Breakdown by Type (2021-2026)
3 SPECT Radiopharmaceuticals Market by Application
- 3.1 Type Introduction
- 3.1.1 Cardiac Imaging
- 3.1.2 Brain Imaging
- 3.1.3 Thyroid Imaging
- 3.1.4 Infection and Inflammation Imaging
- 3.1.5 Cancer Imaging
- 3.2 Global SPECT Radiopharmaceuticals Market Size by Application
- 3.2.1 Global SPECT Radiopharmaceuticals Market Size Overview by Application (2021-2032)
- 3.2.2 Global SPECT Radiopharmaceuticals Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global SPECT Radiopharmaceuticals Market Size Forecasted by Application (2027-2032)
- 3.3 Global SPECT Radiopharmaceuticals Market Size by Regions
- 3.3.1 North America SPECT Radiopharmaceuticals Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe SPECT Radiopharmaceuticals Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America SPECT Radiopharmaceuticals Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa SPECT Radiopharmaceuticals Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 SPECT Radiopharmaceuticals Industry Trends
- 4.2 SPECT Radiopharmaceuticals Industry Drivers
- 4.3 SPECT Radiopharmaceuticals Industry Opportunities and Challenges
- 4.4 SPECT Radiopharmaceuticals Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by SPECT Radiopharmaceuticals Revenue (2021-2026)
- 5.2 Global SPECT Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global SPECT Radiopharmaceuticals Key Company Headquarters & Area Served
- 5.4 Global SPECT Radiopharmaceuticals Company, Product Type & Application
- 5.5 Global SPECT Radiopharmaceuticals Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global SPECT Radiopharmaceuticals Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 SPECT Radiopharmaceuticals Players Market Share by Revenue in 2025
- 5.6.3 2025 SPECT Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Siemens Healthineers
- 6.1.1 Siemens Healthineers Company Information
- 6.1.2 Siemens Healthineers Business Overview
- 6.1.3 Siemens Healthineers SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Siemens Healthineers SPECT Radiopharmaceuticals Product Portfolio
- 6.1.5 Siemens Healthineers Recent Developments
- 6.2 NorthStar Medical Radioisotopes
- 6.2.1 NorthStar Medical Radioisotopes Company Information
- 6.2.2 NorthStar Medical Radioisotopes Business Overview
- 6.2.3 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Portfolio
- 6.2.5 NorthStar Medical Radioisotopes Recent Developments
- 6.3 Molecular Imaging, Inc.
- 6.3.1 Molecular Imaging, Inc. Company Information
- 6.3.2 Molecular Imaging, Inc. Business Overview
- 6.3.3 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Portfolio
- 6.3.5 Molecular Imaging, Inc. Recent Developments
- 6.4 Lantheus Medical Imaging
- 6.4.1 Lantheus Medical Imaging Company Information
- 6.4.2 Lantheus Medical Imaging Business Overview
- 6.4.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Portfolio
- 6.4.5 Lantheus Medical Imaging Recent Developments
- 6.5 IBA Molecular Imaging
- 6.5.1 IBA Molecular Imaging Company Information
- 6.5.2 IBA Molecular Imaging Business Overview
- 6.5.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Portfolio
- 6.5.5 IBA Molecular Imaging Recent Developments
- 6.6 GE Healthcare
- 6.6.1 GE Healthcare Company Information
- 6.6.2 GE Healthcare Business Overview
- 6.6.3 GE Healthcare SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GE Healthcare SPECT Radiopharmaceuticals Product Portfolio
- 6.6.5 GE Healthcare Recent Developments
- 6.7 Eczacibasi-Monrol
- 6.7.1 Eczacibasi-Monrol Company Information
- 6.7.2 Eczacibasi-Monrol Business Overview
- 6.7.3 Eczacibasi-Monrol SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Portfolio
- 6.7.5 Eczacibasi-Monrol Recent Developments
- 6.8 Curium Pharma
- 6.8.1 Curium Pharma Company Information
- 6.8.2 Curium Pharma Business Overview
- 6.8.3 Curium Pharma SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Curium Pharma SPECT Radiopharmaceuticals Product Portfolio
- 6.8.5 Curium Pharma Recent Developments
- 6.9 Cardinal Health
- 6.9.1 Cardinal Health Company Information
- 6.9.2 Cardinal Health Business Overview
- 6.9.3 Cardinal Health SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Cardinal Health SPECT Radiopharmaceuticals Product Portfolio
- 6.9.5 Cardinal Health Recent Developments
- 6.10 Bracco Imaging
- 6.10.1 Bracco Imaging Company Information
- 6.10.2 Bracco Imaging Business Overview
- 6.10.3 Bracco Imaging SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Bracco Imaging SPECT Radiopharmaceuticals Product Portfolio
- 6.10.5 Bracco Imaging Recent Developments
- 6.11 Bayer (Radiology Division)
- 6.11.1 Bayer (Radiology Division) Company Information
- 6.11.2 Bayer (Radiology Division) Business Overview
- 6.11.3 Bayer (Radiology Division) SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Portfolio
- 6.11.5 Bayer (Radiology Division) Recent Developments
- 6.12 Advanced Accelerator Applications
- 6.12.1 Advanced Accelerator Applications Company Information
- 6.12.2 Advanced Accelerator Applications Business Overview
- 6.12.3 Advanced Accelerator Applications SPECT Radiopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Portfolio
- 6.12.5 Advanced Accelerator Applications Recent Developments
7 North America
- 7.1 North America SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 7.3 North America SPECT Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 8.3 Europe SPECT Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 9.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 10.3 South America SPECT Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
- 11.3 Middle East & Africa SPECT Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst